Finance

Beta
Lists
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
$48.78
-0.90%
(-0.44) 1D
Jun 5, 1:15:59 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KNSA...
Open
$48.98
High
$49.99
Low
$48.65
Mkt. cap
3.75B
Avg. vol.
713.84K
Volume
99.87K
P/E ratio
53.81
52-wk high
$59.87
52-wk low
$26.27
EPS
$0.91
Beta
0.12
Shares outstanding
46.30M
No. of employees
366
Open
$48.98
High
$49.99
Low
$48.65
Mkt. cap
3.75B
Avg. vol.
713.84K
Volume
99.87K
P/E ratio
53.81
52-wk high
$59.87
52-wk low
$26.27
EPS
$0.91
Beta
0.12
Shares outstanding
46.30M
No. of employees
366
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to KNSA in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KNSA in the last 3 months.
Highest
Current $48.78
$72.00 (+47.59%)
Average
$64.00 (+31.19%)
Lowest
$57.00 (+16.84%)
News stories
From sources across the web
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquarters-
SectorBiotechnology
Websitekiniksa.com
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.27 / $0.16
+68.75%beat
Revenue / Est. (USD)
214.27M / 206.09M
+3.97%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
156.80M
180.86M
202.13M
214.27M
Cost of goods sold
71.02M
83.56M
90.98M
96.37M
Cost of revenue
71.02M
83.56M
90.98M
96.37M
Research and development expenses
18.75M
24.17M
34.61M
27.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.86M
49.10M
56.78M
61.15M
Operating expense
65.62M
73.27M
91.38M
88.63M
Total operating expenses
136.64M
156.83M
182.36M
185.00M
Operating income
20.16M
24.02M
19.77M
29.27M
Other non operating income
2.72M
3.14M
3.50M
3.41M
EBT including unusual items
22.88M
27.16M
23.27M
32.68M
EBT excluding unusual items
22.88M
27.16M
23.27M
32.68M
Income tax expense
5.04M
8.72M
9.07M
10.09M
Effective tax rate
22.05%
32.12%
38.98%
30.87%
Other operating expenses
-
-
-
-
Net income
17.83M
18.44M
14.20M
22.59M
Net profit margin
11.37%
10.19%
7.02%
10.54%
Earnings per share
0.23
0.23
0.17
0.27
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
20.52M
24.40M
20.24M
29.74M
Gain or loss from assets sale
-34.00K
-43.00K
-53.00K
-54.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer